β-Amyloid Clustering around ASC Fibrils Boosts Its Toxicity in Microglia

Lea L Friker1, Hannah Scheiblich1, Inga V Hochheiser2

  • 1Department of Neurodegenerative Disease and Gerontopsychiatry/Neurology, University of Bonn Medical Center, 53127 Bonn, Germany.

Cell Reports
|March 19, 2020
PubMed

Insights

Alzheimer's disease involves neuroinflammation where apoptosis-associated speck-like protein containing a CARD (ASC) can spread between microglia. ASC-beta-amyloid (Aβ) composites worsen inflammation and impair Aβ clearance, creating a detrimental cycle.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Alzheimer's disease (AD) is a leading neurodegenerative disorder characterized by neuroinflammation.
  • Microglia activation by beta-amyloid (Aβ) deposits is central to AD pathogenesis.
  • Apoptosis-associated speck-like protein containing a CARD (ASC) has been implicated in binding and cross-seeding extracellular Aβ.

Purpose of the Study:

  • To investigate the propagation of ASC between primary microglia.
  • To determine the effects of ASC-Aβ composites on microglial inflammasomes and function.
  • To elucidate the role of ASC in the transition from acute to chronic neuroinflammation in AD.

Main Methods:

  • Primary microglia cultures were utilized.
  • Exposure to ASC-Aβ composites was performed.
  • Microglial inflammasome activation, pyroptosis, and Aβ clearance were assessed.

Main Results:

  • ASC released from pyroptotic cells is incorporated into neighboring microglia's NOD-like receptor protein (NLRP3) inflammasome.
  • ASC-Aβ composites significantly amplify the proinflammatory response compared to protein alone.
  • ASC-Aβ composites induce pyroptotic cell death, releasing more ASC and creating a feedforward inflammatory loop.
  • Microglial Aβ clearance is impaired by clustering around ASC fibrils.

Conclusions:

  • ASC propagation and formation of ASC-Aβ composites represent a critical turning point in Alzheimer's disease.
  • These interactions exacerbate neuroinflammation and hinder Aβ clearance, driving disease progression.
  • Targeting ASC-Aβ interactions may offer a therapeutic strategy for Alzheimer's disease.